Characterization of Palytoxin Binding to HaCaT Cells Using a Monoclonal Anti-Palytoxin Antibody

Palytoxin (PLTX) is the reference compound for a group of potent marine biotoxins, for which the molecular target is Na+/K+-ATPase. Indeed, ouabain (OUA), a potent blocker of the pump, is used to inhibit some PLTX effects in vitro. However, in an effort to explain incomplete inhibition of PLTX cytot...

Full description

Bibliographic Details
Main Authors: Chiara Florio, Aurelia Tubaro, Silvio Sosa, Marco Pelin, Mark Poli, Sabrina Boscolo
Format: Article
Language:English
Published: MDPI AG 2013-02-01
Series:Marine Drugs
Subjects:
Online Access:http://www.mdpi.com/1660-3397/11/3/584
_version_ 1828370504498544640
author Chiara Florio
Aurelia Tubaro
Silvio Sosa
Marco Pelin
Mark Poli
Sabrina Boscolo
author_facet Chiara Florio
Aurelia Tubaro
Silvio Sosa
Marco Pelin
Mark Poli
Sabrina Boscolo
author_sort Chiara Florio
collection DOAJ
description Palytoxin (PLTX) is the reference compound for a group of potent marine biotoxins, for which the molecular target is Na+/K+-ATPase. Indeed, ouabain (OUA), a potent blocker of the pump, is used to inhibit some PLTX effects in vitro. However, in an effort to explain incomplete inhibition of PLTX cytotoxicity, some studies suggest the possibility of two different binding sites on Na+/K+-ATPase. Hence, this study was performed to characterize PLTX binding to intact HaCaT keratinocytes and to investigate the ability of OUA to compete for this binding. PLTX binding to HaCaT cells was demonstrated by immunocytochemical analysis after 10 min exposure. An anti-PLTX monoclonal antibody-based ELISA showed that the binding was saturable and reversible, with a Kd of 3 × 10−10 M. However, kinetic experiments revealed that PLTX binding dissociation was incomplete, suggesting an additional, OUA-insensitive, PLTX binding site. Competitive experiments suggested that OUA acts as a negative allosteric modulator against high PLTX concentrations (0.3–1.0 × 10−7 M) and possibly as a non-competitive antagonist against low PLTX concentrations (0.1–3.0 × 10−9 M). Antagonism was supported by PLTX cytotoxicity inhibition at OUA concentrations that displaced PLTX binding (1 × 10−5 M). However, this inhibition was incomplete, supporting the existence of both OUA-sensitive and -insensitive PLTX binding sites.
first_indexed 2024-04-14T06:38:52Z
format Article
id doaj.art-021ea625d1c9425ca52448c137e19bc3
institution Directory Open Access Journal
issn 1660-3397
language English
last_indexed 2024-04-14T06:38:52Z
publishDate 2013-02-01
publisher MDPI AG
record_format Article
series Marine Drugs
spelling doaj.art-021ea625d1c9425ca52448c137e19bc32022-12-22T02:07:23ZengMDPI AGMarine Drugs1660-33972013-02-0111358459810.3390/md11030584Characterization of Palytoxin Binding to HaCaT Cells Using a Monoclonal Anti-Palytoxin AntibodyChiara FlorioAurelia TubaroSilvio SosaMarco PelinMark PoliSabrina BoscoloPalytoxin (PLTX) is the reference compound for a group of potent marine biotoxins, for which the molecular target is Na+/K+-ATPase. Indeed, ouabain (OUA), a potent blocker of the pump, is used to inhibit some PLTX effects in vitro. However, in an effort to explain incomplete inhibition of PLTX cytotoxicity, some studies suggest the possibility of two different binding sites on Na+/K+-ATPase. Hence, this study was performed to characterize PLTX binding to intact HaCaT keratinocytes and to investigate the ability of OUA to compete for this binding. PLTX binding to HaCaT cells was demonstrated by immunocytochemical analysis after 10 min exposure. An anti-PLTX monoclonal antibody-based ELISA showed that the binding was saturable and reversible, with a Kd of 3 × 10−10 M. However, kinetic experiments revealed that PLTX binding dissociation was incomplete, suggesting an additional, OUA-insensitive, PLTX binding site. Competitive experiments suggested that OUA acts as a negative allosteric modulator against high PLTX concentrations (0.3–1.0 × 10−7 M) and possibly as a non-competitive antagonist against low PLTX concentrations (0.1–3.0 × 10−9 M). Antagonism was supported by PLTX cytotoxicity inhibition at OUA concentrations that displaced PLTX binding (1 × 10−5 M). However, this inhibition was incomplete, supporting the existence of both OUA-sensitive and -insensitive PLTX binding sites.http://www.mdpi.com/1660-3397/11/3/584palytoxinouabainbindingELISAHaCaT cells
spellingShingle Chiara Florio
Aurelia Tubaro
Silvio Sosa
Marco Pelin
Mark Poli
Sabrina Boscolo
Characterization of Palytoxin Binding to HaCaT Cells Using a Monoclonal Anti-Palytoxin Antibody
Marine Drugs
palytoxin
ouabain
binding
ELISA
HaCaT cells
title Characterization of Palytoxin Binding to HaCaT Cells Using a Monoclonal Anti-Palytoxin Antibody
title_full Characterization of Palytoxin Binding to HaCaT Cells Using a Monoclonal Anti-Palytoxin Antibody
title_fullStr Characterization of Palytoxin Binding to HaCaT Cells Using a Monoclonal Anti-Palytoxin Antibody
title_full_unstemmed Characterization of Palytoxin Binding to HaCaT Cells Using a Monoclonal Anti-Palytoxin Antibody
title_short Characterization of Palytoxin Binding to HaCaT Cells Using a Monoclonal Anti-Palytoxin Antibody
title_sort characterization of palytoxin binding to hacat cells using a monoclonal anti palytoxin antibody
topic palytoxin
ouabain
binding
ELISA
HaCaT cells
url http://www.mdpi.com/1660-3397/11/3/584
work_keys_str_mv AT chiaraflorio characterizationofpalytoxinbindingtohacatcellsusingamonoclonalantipalytoxinantibody
AT aureliatubaro characterizationofpalytoxinbindingtohacatcellsusingamonoclonalantipalytoxinantibody
AT silviososa characterizationofpalytoxinbindingtohacatcellsusingamonoclonalantipalytoxinantibody
AT marcopelin characterizationofpalytoxinbindingtohacatcellsusingamonoclonalantipalytoxinantibody
AT markpoli characterizationofpalytoxinbindingtohacatcellsusingamonoclonalantipalytoxinantibody
AT sabrinaboscolo characterizationofpalytoxinbindingtohacatcellsusingamonoclonalantipalytoxinantibody